BIOMAT Database Logo BIOMAT Database Logo

[mRNA breakdown in tumor cells in vivo under cycloheximide protein synthesis inhibition]. 1979

V A Arbuzov, and G D Krechetova, and M I Pigareva

Amoung of prelabelled mRNA was unaltered in Zajhdel ascites hepatoma of rat cells within 3.5-4 hrs under conditions of treatment with actinomycin D. Due to combined effect of actinomycin D and cycloheximide the content of mRNA in the hepatoma cells was rapidly decreased. Degradation of mRNA occurred in membrane-bound polyribosomes, free polyribosomes and in cytoplasmic mRNP-particles /informosomes/ as a result of the effect of cycloheximide. Simultaneously with these phenomena, distinct increase in activity of acid and alkaline RNAases was observed in cytoplasma of the hepatoma cells; activity of endoRNAase from membrane-bound and free polyribosomes of the hepatoma was also markedly increased. Cycloheximide did not affect the activity of polynucleotide phosphorylase in polyribosomes of the hepatoma cells. Labile proteins, responsible for inhibition of RNAses appeart to participate in regulation of mRNA stability in malignant cells.

UI MeSH Term Description Entries
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011117 Polyribonucleotide Nucleotidyltransferase An enzyme of the transferase class that catalyzes the reaction RNA(n+1) and orthophosphate to yield RNA(n) and a nucleoside diphosphate, or the reverse reaction. ADP, IDP, GDP, UDP, and CDP can act as donors in the latter case. (From Dorland, 27th ed) EC 2.7.7.8. Polynucleotide Phosphorylase,Nucleotidyltransferase, Polyribonucleotide,Phosphorylase, Polynucleotide
D011132 Polyribosomes A multiribosomal structure representing a linear array of RIBOSOMES held together by messenger RNA; (RNA, MESSENGER); They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Polysomes,Polyribosome,Polysome
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical

Related Publications

V A Arbuzov, and G D Krechetova, and M I Pigareva
[Stabilization of polyribosomal mRNA in rat liver cells under protein synthesis inhibition by cycloheximide].
May 1978, Biokhimiia (Moscow, Russia),
V A Arbuzov, and G D Krechetova, and M I Pigareva
CYCLOHEXIMIDE: ASPECTS OF INHIBITION OF PROTEIN SYNTHESIS IN MAMMALIAN CELLS.
December 1964, Science (New York, N.Y.),
V A Arbuzov, and G D Krechetova, and M I Pigareva
Combined electroconvulsive shock and cycloheximide inhibition of brain protein synthesis in vivo.
June 1976, Behavioral biology,
V A Arbuzov, and G D Krechetova, and M I Pigareva
Inhibition of glycoprotein synthesis by cycloheximide in liver and Ehrlich tumor cells.
October 1971, Biochimica et biophysica acta,
V A Arbuzov, and G D Krechetova, and M I Pigareva
INHIBITION OF PROTEIN SYNTHESIS IN VITRO BY CYCLOHEXIMIDE.
November 1963, Nature,
V A Arbuzov, and G D Krechetova, and M I Pigareva
Synthesis of ribonucleic acid in L cells during inhibition of protein synthesis by cycloheximide.
November 1966, Molecular pharmacology,
V A Arbuzov, and G D Krechetova, and M I Pigareva
Inhibition of protein synthesis by cycloheximide (Actidione) in Chlorella.
September 1966, Nature,
V A Arbuzov, and G D Krechetova, and M I Pigareva
INHIBITION OF PROTEIN SYNTHESIS BY CYCLOHEXIMIDE IN RABBIT RETICULOCYTES.
February 1965, Biochemical and biophysical research communications,
V A Arbuzov, and G D Krechetova, and M I Pigareva
Regulation of mammalian protein synthesis in vivo. Stimulated protein synthesis in liver in vivo after cycloheximide treatment.
March 1977, The Biochemical journal,
V A Arbuzov, and G D Krechetova, and M I Pigareva
[Cycloheximide inhibition of nuclear-cytoplasmic mRNA transport in rat liver cells].
January 1977, Doklady Akademii nauk SSSR,
Copied contents to your clipboard!